SCHEMBL9764439

SCHEMBL9764439

CN(C)CCc1ccc(CCCOCCCCCCNCC(O)c2cc(Cl)c(N)c(Cl)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC2A1 P11166 1/20 0.49
▸ ADRB2 P07550 15/20 0.48
▸ ADRB1 P08588 13/20 0.46
▸ ADRB3 P13945 10/20 0.46
▸ SLC6A2 P23975 2/20 0.46
▸ HTR2A P28223 2/20 0.46
▸ SLC6A4 P31645 2/20 0.46
▸ ADRA1A P35348 2/20 0.46
▸ SLC6A3 Q01959 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ HTR1A P08908 1/20 0.46
▸ CHRM5 P08912 1/20 0.46
▸ DRD2 P14416 1/20 0.46
▸ ADRA2B P18089 1/20 0.46
▸ DRD4 P21917 1/20 0.46
▸ FPR3 P25089 1/20 0.46
▸ ADRA1D P25100 1/20 0.46
▸ HTR1D P28221 1/20 0.46
▸ HTR1B P28222 1/20 0.46
▸ HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764530 0.92 SLC2A1 (0.48) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764474 0.88 ADRB2 (0.53) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764505 0.87 SLC2A1 (0.50) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764442 0.87 ADRB2 (0.53) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764599 0.87 SLC2A1 (0.51) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764235 0.86 ADRB2 (0.49) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764767 0.86 SLC2A1 (0.48) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764441 0.85 SLC2A1 (0.49) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL10417908 0.85 SLC2A1 (0.55) SLC2A1ADRB2ADRB1ADRB3SLC6A2
SCHEMBL9764380 0.85 ADRB2 (0.53) SLC2A1ADRB2ADRB1ADRB3SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5006556-A Dichloroaniline derivatives for the therapy or prophylaxysis of a disease associated with reversible airway obstruction GLAXO GROUP LIMITED (GB) 1991-04-09 — — US disclosed
US-4943591-A TREATMENT OF ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1990-07-24 — — US disclosed
Send feedback